Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer

Clinical Biochemistry

Volumn 41, Issue 16-17, 2008, Pages 1335-1341

  Eissa, Sanaa ^a   Zohny, Samir F ^b   Swellam, Menha ^c   Mahmoud, Manar H ^a   El Zayat, Tarek Mostafa ^a   Salem, Ahmed M ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Ain Shams University   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Bladder cancer; CD44; CK20 mRNA; Urine cytology

Indexed keywords

CYTOKERATIN 20; HERMES ANTIGEN; MESSENGER RNA;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLADDER CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; URINE CYTOLOGY; VOIDED URINE CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-20; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 55249101186     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.08.085     Document Type: Article

References (31)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J. Clin. 58 (2008) 71-96
2. El Mawla N.G., El Bolkainy M.N., and Khaled H.M. Bladder cancer in Africa: update. Semin. Oncol. 28 (2001) 174-178
3. El-Sebaie M., Zaghloul M.S., Howard G., and Mokhtar A. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management. Int. J. Clin. Oncol. 10 (2005) 20-25
4. Dey P. Urinary markers of bladder carcinoma. Clin. Chim. Acta 340 (2004) 57-65
5. Eissa S., Kassim S., and El-Ahmady O. Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers. Curr. Opin. Obstet. Gynecol. 15 (2003) 395-403
6. Miyake H., Hara I., Kamidono S., and Eto H. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns. J. Urol. 172 (2004) 1127-1129
7. Naor D., Wallach-Dayan S.B., Zahalka M.A., and Sionov R.V. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin. Cancer Biol. 18 (2008) 260-267
8. Okamoto I., Morisaki T., Sasaki J., et al. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs. J. Natl. Cancer Inst. 90 (1998) 307-315
9. Miyake H., Hara I., Arakawa S., and Kamidono S. Utility of competitive transcription-polymerase chain reaction analysis of specific CD44 variant RNA for detecting upper urinary tract transitional-cell carcinoma. Mol. Urol. 3 (1999) 365-370
10. Barak V., Goike H., Panaretakis K.W., and Einarsson R. Clinical utility of cytokeratins as tumor markers. Clin. Biochem. 37 (2004) 529-540
11. th ed. (1997), Lippincott-Raven, Philadelphia 241
12. th ed. (1997), Wiley Liss, New York 187
13. Eissa S., Labib R.A., Mourad M.S., Kamel K., and El-Ahmady O. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer. Eur. Urol. 44 (2003) 687-694
14. Gui M., Idris M.A., Shi Y.E., Muhling A., and Ruppel A. Reactivity of Schistosoma japonicum and S. mansoni antigen preparations in indirect haemagglutination (IHA) with sera of patients with homologous and heterologous schistosomiasis. Ann. Trop. Med. Parasitol. 85 (1991) 599-604
15. Papanicolaou G.N., and Marshall V.F. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 101 (1945) 519-520
16. Eissa S., Ahmed M.I., Said H., Zaghlool A., and El-Ahmady O. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. IUBMB Life 56 (2004) 557-564
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
18. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning. A laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY) 42-59
19. Eissa S., Kenawy G., Swellam M., Abou El-Fadle A., Abd El-Aal A.A., and El-Ahmady O. Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma. Clin. Biochem. 37 (2004) 803-810
20. Eissa S., Kassim S.K., Labib R.A., et al. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs. Cancer 103 (2005) 1356-1362
21. Burchill S.A., Bradbury M.F., Pittman K., Southgate J., Smith B., and Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br. J. Cancer 71 (1995) 278-281
22. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
23. Frimberger D., Zaak D., and Hofstetter A. Endoscopic fluorescence diagnosis and laser treatment of transitional cell carcinoma of bladder. Semin. Urol. Oncol. 18 (2000) 264-272
24. Lotan Y, Roehrborn CG. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analysis. Urology;61:109-18.
25. Lesley J., Hyman R., and Kincade P.W. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54 (1993) 271-335
26. Golshani R., Lopez L., Estrella V., Kramer M., Iida N., and Lokeshwar V.B. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res. 68 (2008) 483-491
27. Siracusano S., Niccolini B., Knez R., et al. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine. Eur. Urol. 47 (2005) 327-333
28. Christoph F., Weikert S., Wolff I., et al. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder. Cancer Lett. 245 (2007) 121-126
29. Sugiyama M., Woodman A., Sugino T., et al. Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. Clin. Mol. Pathol. 48 (1995) M142-M147
30. Eissa S., Ali-Labib R., Swellam M., Bassiony M., Tash F., and El-Zayat T.M. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur. Urol. 52 (2007) 1388-1397
31. Bian W., and Xu Z. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma. Int. J. Urol. 14 (2007) 108-111